Bambusa Therapeutics Inc. BBTX

website

Bambusa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in dev...

Price16.94

Market Cap801.32 M

Float10.56 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

BBTX Bambusa Therapeutics Inc.

Price$16.94

Company About

Bambusa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases. The company was founded by Shan Shan Xu, Thang Ho, and Helmut Jeggle on March 14, 2024 and is headquartered in Boston, MA.

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

NASDAQ

Vol Avg.

633.43 K

Inst Own

Float & OS

10.56 M / 50.94 M

Cash/Shr

Market Cap & Ev

801.32 M / N/A

Short Interest

Borrow Rate

12.0806%

Days to Cover

Research Report

Customize research

Recent Articles (1)

View All

Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering

PRNewswire

Oct 29, 2026, 8:15 PM

Recent Filings

View All

Type	Title	Date Released
SCHEDULE 13D	RA CAPITAL MANAGEMENT, L.P. (Filed by)	Nov 6, 2026, 4:20 PM
SCHEDULE 13G	ATHOS KG (Filed by)	Nov 5, 2026, 8:30 PM
4	RA Capital Healthcare Fund LP (Reporting)	Nov 3, 2026, 6:09 PM
8-K	Bambusa Therapeutics Completes Initial Public Offering and Adopts Amended Corporate Governance Documents	Nov 2, 2026, 6:19 PM
4	Salvia Investment GmbH (Reporting)	Nov 2, 2026, 4:07 PM
4	Jeggle Helmut Wolfgang (Reporting)	Nov 2, 2026, 4:06 PM
4	Xu Shanshan (Reporting)	Nov 2, 2026, 4:04 PM
4	Xu Shanshan (Reporting)	Nov 2, 2026, 4:01 PM
424B4	Form 424B4	Oct 30, 2026, 4:02 PM
EFFECT	Form EFFECT	Oct 30, 2026, 12:15 AM
S-8	Form S-8	Oct 29, 2026, 7:42 PM
S-1MEF	Form S-1MEF	Oct 29, 2026, 5:19 PM

Earnings

Related Healthcare stocks

All tickers